Sponsor or institution
Clinical trials and research at First Affiliated Hospital, Sun Yat-Sen University
As of November 12, 2026, Find a Trial lists 24 clinical trials run by First Affiliated Hospital, Sun Yat-Sen University that are recruiting, in China. By phase: Phase 4 (4), Phase 3 (3), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 24Clinical trials
- 1Country
Newest trials
All recruiting trials (24)
-
Different Frequency Temporal Interference Stimulation for Parkinson’s Disease
This trial tests whether using two different stimulation frequencies on opposite sides of the brain can improve movement and speech in people with Parkinson’s.
-
Human Sinonasal Mucosa Map Across Nasal Regions
This observational study will test whether tissues from different parts of the nose and sinuses have distinct biological features in adults undergoing sinus surgery.
-
Accelerated temporal interference stimulation of the bilateral subthalamic nuclei for Parkinson's disease
This study will see if accelerated temporal interference stimulation applied to both subthalamic nuclei helps improve movement and speech in people with Parkinson's disease or secondary parkinsonism.
-
Rapidly constructed tissue-engineered skin to repair hard-to-heal wounds
This trial tries a fast, personalized skin graft made from your own epidermal stem cells to see if it heals hard-to-heal wounds faster and with fewer complications than a standard graft.
-
Comparing DEB-TACE and cTACE for liver cancer after TIPS
This trial will test whether DEB-TACE or conventional TACE works better and is safer for people with hepatocellular carcinoma beyond Milan criteria who previously had a TIPS.
-
AI-powered multimodal imaging for diagnosing and predicting digestive disease outcomes
This project will test an AI tool that combines CT and MR enterography with endoscopy data to help diagnose and predict outcomes for people with Crohn's disease, ulcerative colitis, intestinal tuberculosis, or Behçet's disease.
-
Observing the effects of rituximab in treating primary membranous nephropathy
This study is testing whether adding hormones to rituximab can help people with primary membranous nephropathy feel better compared to using rituximab alone.
-
PIMS versus PGT-A for embryo selection in women with PCOS
This test will see if selecting embryos with Pre-implantation Methylation Screening (PIMS) instead of PGT-A plus standard morphology leads to higher cumulative live birth rates and lower early pregnancy loss for women with PCOS undergoing IVF/ICSI.
-
AI-enhanced MRE to detect bowel fibrosis in Crohn's disease
This project will test whether an AI program applied to magnetic resonance enterography (MRE) scans can accurately identify and characterize bowel wall fibrosis in adults with Crohn's disease who are scheduled for bowel resection.
-
Early lifestyle program for pregnant women with mildly high early-pregnancy blood sugar
This program tests whether starting diet, exercise, weight management and home blood‑glucose monitoring early in pregnancy helps women with mildly high early-pregnancy blood sugar have fewer large babies and preterm births.
-
Long-term outcomes for patients with lupus nephritis in China
This study looks at how well people with lupus nephritis in China do over the long term to see if their kidney health and survival rates have improved since their diagnosis.
-
Intrathecal morphine for pain control after major laparoscopic abdominal surgery
This trial will test whether adding a single intrathecal morphine injection to usual care improves early recovery and pain for adults having major laparoscopic abdominal surgery.
-
Finerenone for primary membranous nephropathy: efficacy and safety
This trial tests whether adding finerenone to standard ACEI/ARB treatment lowers urine protein over six months in adults with primary membranous nephropathy.
-
Evaluating treatments for arteriosclerosis obliterans
This study is testing different treatments for arteriosclerosis obliterans to see which ones work best and are most cost-effective for people with this condition.
-
Blocking blood supply to treat glioblastoma
This study is testing a new procedure that blocks blood flow to glioblastoma tumors to see if it can help the immune system fight the cancer better in people who haven't had treatment yet.
-
Comparing two versus three cycles of chemotherapy for advanced nasopharyngeal cancer
This study is testing whether two cycles of chemotherapy before radiation is just as effective as three cycles for people with advanced nasopharyngeal cancer.
-
Combination therapy for early breast cancer with HRR gene mutation
This study is testing a new combination of three drugs to see if it helps people with early-stage HER2-negative breast cancer and specific gene mutations feel better before surgery.
-
Using icodextrin to delay full dose dialysis in patients on incremental peritoneal dialysis
This study is testing if icodextrin can help patients on low dose peritoneal dialysis delay moving to full dose dialysis during their first year of treatment.
-
Treatment of Primary Membranous Nephropathy with Rituximab and Corticosteroids
This study is testing whether combining rituximab with corticosteroids works better than just rituximab alone for treating primary membranous nephropathy in people who haven't been treated before.
-
Evaluating Avapritinib for Advanced Gastrointestinal Stromal Tumors
This study is testing if Avapritinib can help people with advanced gastrointestinal stromal tumors feel better and improve their health in real-world situations.
-
Using Avapritinib for treating specific types of gastrointestinal stromal tumors
This study is testing if Avapritinib can help people with hard-to-treat gastrointestinal stromal tumors that have specific gene mutations feel better and live longer.
-
Comparing two treatment approaches for advanced nasopharyngeal cancer
This study is testing two different treatment plans for advanced nasopharyngeal cancer to see if one works just as well as the other for patients.
-
Developing an intelligent system for diagnosing nasopharyngeal carcinoma
This study is testing a new smart system that uses artificial intelligence to help doctors find early signs of nasopharyngeal carcinoma in patients who are at high risk.
-
Repairing scars with tissue-engineered skin grafts
This study is testing a new way to treat stubborn scars using skin grafts made from the patient's own cells to see if it can improve healing and reduce costs.
Quick answers
How many clinical trials run by First Affiliated Hospital, Sun Yat-Sen University are recruiting right now?
24, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 4, Phase 3: 3, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.